SCHEMBL4434941

SCHEMBL4434941

C=C(C(=O)O)c1ccc(N2CCOCC2)nc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
POLB P06746 2/20 0.61
HPGD P15428 2/20 0.61
HSD17B10 Q99714 2/20 0.61
KDM4E B2RXH2 1/20 0.61
ALOX15 P16050 1/20 0.61
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C19 P33261 1/20 0.52
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
STAT3 P40763 1/20 0.50
ADRA1A P35348 2/20 0.49
KCNQ3 O43525 1/20 0.49
KCNQ2 O43526 1/20 0.49
PIK3CA P42336 1/20 0.49
CYP2C9 P11712 1/20 0.49
USP30 Q70CQ3 1/20 0.48
AKR1C3 P42330 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63778 0.85 ALDH1A1 (0.73) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL13271450 0.84 ALDH1A1 (0.60) ALDH1A1POLBHPGDHSD17B10KDM4E
Hydrochloric Acid SCHEMBL19119306 0.84 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL31283651 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL357927 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL23655010 0.81 ALDH1A1 (0.62) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL19160257 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL209882 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL2974981 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E
SCHEMBL243892 0.81 ALDH1A1 (0.71) ALDH1A1POLBHPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054411-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2009-05-06 EP disclosed
WO-2008013414-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2008-01-31 WO disclosed